Get the Stockscreener App
58.83
0.73%
0.4272
After Hours:
58.85
0.0228
+0.04%
Global X Genomics Biotechnology Etf stock is traded at $58.83, with a volume of 46,111.
It is up +0.73% in the last 24 hours and up +21.13% over the past month.
See More
Previous Close:
$58.40
Open:
$58.4
24h Volume:
46,111
Relative Volume:
2.81
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+2.99%
1M Performance:
+21.13%
6M Performance:
+22.99%
1Y Performance:
+68.46%
1-Day Range:
$57.67
$59.48
1-Week Range:
$56.44
$59.48
52-Week Range:
$34.04
$59.48
Global X Genomics Biotechnology Etf Stock (GNOM) Company Profile
Name
Global X Genomics Biotechnology Etf
Sector
Industry
Phone
-
Address
-
Compare GNOM vs VTI, SPY, IVV, VB, QQQ
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GNOM
Global X Genomics Biotechnology Etf
|
58.83 | 0 | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
371.67 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
751.28 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
754.76 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
301.66 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
722.82 | 124.43B | 0 | 0 | 0 | 0.00 |
Global X Genomics Biotechnology Etf Stock (GNOM) Latest News
Genomics & biotechnology ETF declares semi-annual distribution of $0.057900 - MSN
Global X Fds Genomics & Biotechnology Etf To Go Ex-Dividend On June 29th, 2026 With 0.05789 USD Dividend Per Share - Moomoo
GNMX Stock Fund Price and Chart — CBOE:GNMX - TradingView
Biotech ETFs Put Up Strong Show in 1H 2026: More Gains Ahead? - TradingView
Pacific Biosciences of California Inc (PACB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Guardant Health Inc (GH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Praxis Precision Medicines Inc (PRAX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Illumina Inc (ILMN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
2Seventy Bio Inc (TSVT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Biontech SE (BNTX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
WAVE Life Sciences Ltd (WVE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Moderna Inc (MRNA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Uniqure NV (QURE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Bio-Techne Corp (TECH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CARGO Therapeutics Inc (CRGX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Arrowhead Pharmaceuticals Inc (ARWR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Veracyte Inc (VCYT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Beam Therapeutics Inc (BEAM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Ultragenyx Pharmaceutical Inc (RARE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Natera Inc (NTRA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CareDx Inc (CDNA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
BioMarin Pharmaceutical Inc (BMRN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
GeneDx Holdings Corp (WGS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CureVac NV (CVAC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Sangamo Therapeutics Inc (SGMO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Avidity Biosciences Inc (RNA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Rocket Pharmaceuticals Inc (RCKT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Qiagen NV (QGEN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Myriad Genetics Inc (MYGN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Personalis Inc (PSNL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Allogene Therapeutics Inc (ALLO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CRISPR Therapeutics AG (CRSP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Sarepta Therapeutics Inc (SRPT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Sana Biotechnology Inc (SANA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Vir Biotechnology Inc (VIR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Twist Bioscience Corp (TWST) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
10X Genomics Inc (TXG) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Alnylam Pharmaceuticals Inc (ALNY) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Legend Biotech Corp (LEGN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Arcturus Therapeutics Holdings Inc (ARCT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Prime Medicine Inc (PRME) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Intellia Therapeutics Inc (NTLA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Price-Driven Insight from (GNOM) for Rule-Based Strategy - Stock Traders Daily
(GNOM) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
5 Small-cap Biotech ETFs to Watch in 2026 - Investing News Network
(GNOM) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Emerge launches five innovation-focused ETFs - Advisor.ca
Why Is Global XGenomics & Biotechnology ETF (GNOM) Stock Up Today? - Meyka
(GNOM) Risk Channels and Responsive Allocation - Stock Traders Daily
Best CRISPR Gene Editing ETFs for 2026 and How to Invest - The Motley Fool
Global X Rare Earth & Critical Materials ETF (EART) Short Interest & Short Float | Updated May 2026 - MarketBeat
Global X Genomics Biotechnology Etf Stock (GNOM) Financials Data
There is no financial data for Global X Genomics Biotechnology Etf (GNOM). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.12%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):